My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 743

    1.

    Impaired glucose tolerance, but not impaired fasting glucose, is associated with increased levels of coronary heart disease risk factors: results from the Baltimore Longitudinal Study on Aging.

    Blake DR, Meigs JB, Muller DC, Najjar SS, Andres R, Nathan DM.

    Diabetes. 2004 Aug;53(8):2095-100.PMID: 15277391 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the Atherosclerosis Risk in Communities Study.

    Pankow JS, Kwan DK, Duncan BB, Schmidt MI, Couper DJ, Golden S, Ballantyne CM.

    Diabetes Care. 2007 Feb;30(2):325-31.PMID: 17259502 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    The natural history of progression from normal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging.

    Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R; Baltimore Longitudinal Study of Aging.

    Diabetes. 2003 Jun;52(6):1475-84.PMID: 12765960 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Differences in insulin resistance in nondiabetic subjects with isolated impaired glucose tolerance or isolated impaired fasting glucose.

    Festa A, D'Agostino R Jr, Hanley AJ, Karter AJ, Saad MF, Haffner SM.

    Diabetes. 2004 Jun;53(6):1549-55.PMID: 15161760 [PubMed - indexed for MEDLINE]Related articlesFree article

    5.

    Comparison of glucose tolerance categories in the Korean population according to World Health Organization and American Diabetes Association diagnostic criteria.

    Park KS, Park YJ, Kim SW, Shin CS, Park DJ, Koh JJ, Kim SY, Kim NK, Lee HK.

    Korean J Intern Med. 2000 Jan;15(1):37-41.PMID: 10714090 [PubMed - indexed for MEDLINE]Related articles

    6.

    Differences in cardiovascular risk factors, insulin resistance, and insulin secretion in individuals with normal glucose tolerance and in subjects with impaired glucose regulation: the Telde Study.

    Nóvoa FJ, Boronat M, Saavedra P, Díaz-Cremades JM, Varillas VF, La Roche F, Alberiche MP, Carrillo A.

    Diabetes Care. 2005 Oct;28(10):2388-93.PMID: 16186268 [PubMed - indexed for MEDLINE]Related articlesFree article

    7.

    Comparison of the 1997 and 2003 American Diabetes Association classification of impaired fasting glucose: impact on prevalence of impaired fasting glucose, coronary heart disease risk factors, and coronary heart disease in a community-based medical practice.

    Kim SH, Chunawala L, Linde R, Reaven GM.

    J Am Coll Cardiol. 2006 Jul 18;48(2):293-7. Epub 2006 Jun 22.PMID: 16843178 [PubMed - indexed for MEDLINE]Related articles

    8.

    Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention.

    Unwin N, Shaw J, Zimmet P, Alberti KG.

    Diabet Med. 2002 Sep;19(9):708-23. Review.PMID: 12207806 [PubMed - indexed for MEDLINE]Related articles

    9.

    Differences in insulin action and secretion, plasma lipids and blood pressure levels between impaired fasting glucose and impaired glucose tolerance in Japanese subjects.

    Miyazaki Y, Akasaka H, Ohnishi H, Saitoh S, DeFronzo RA, Shimamoto K.

    Hypertens Res. 2008 Jul;31(7):1357-63.PMID: 18957806 [PubMed - indexed for MEDLINE]Related articles

    10.

    Prediction of diabetes using ADA or WHO criteria in post-menopausal women: a 10-year follow-up study.

    Larsson H, Lindgärde F, Berglund G, Ahrén B.

    Diabetologia. 2000 Oct;43(10):1224-8.PMID: 11079739 [PubMed - indexed for MEDLINE]Related articles

    11.

    Impaired fasting glucose is not a risk factor for atherosclerosis.

    Hanefeld M, Temelkova-Kurktschiev T, Schaper F, Henkel E, Siegert G, Koehler C.

    Diabet Med. 1999 Mar;16(3):212-8.PMID: 10227566 [PubMed - indexed for MEDLINE]Related articles

    12.

    Relation of impaired fasting and postload glucose with incident type 2 diabetes in a Dutch population: The Hoorn Study.

    de Vegt F, Dekker JM, Jager A, Hienkens E, Kostense PJ, Stehouwer CD, Nijpels G, Bouter LM, Heine RJ.

    JAMA. 2001 Apr 25;285(16):2109-13.PMID: 11311100 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Determinants of progression from impaired fasting glucose and impaired glucose tolerance to diabetes in a high-risk screened population: 3 year follow-up in the ADDITION study, Denmark.

    Rasmussen SS, Glümer C, Sandbaek A, Lauritzen T, Borch-Johnsen K.

    Diabetologia. 2008 Feb;51(2):249-57. Epub 2007 Dec 5.PMID: 18060659 [PubMed - indexed for MEDLINE]Related articles

    14.

    Impaired fasting glucose and impaired glucose tolerance in urban population in India.

    Ramachandran A, Snehalatha C, Satyavani K, Vijay V.

    Diabet Med. 2003 Mar;20(3):220-4.PMID: 12675667 [PubMed - indexed for MEDLINE]Related articles

    15.

    Cardiovascular risk profile in individuals with borderline glycemia: the effect of the 1997 American Diabetes Association diagnostic criteria and the 1998 World Health Organization Provisional Report.

    Lim SC, Tai ES, Tan BY, Chew SK, Tan CE.

    Diabetes Care. 2000 Mar;23(3):278-82.PMID: 10868851 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study.

    Faerch K, Vaag A, Holst JJ, Hansen T, Jørgensen T, Borch-Johnsen K.

    Diabetes Care. 2009 Mar;32(3):439-44. Epub 2008 Dec 3.PMID: 19056613 [PubMed - indexed for MEDLINE]Related articlesFree article

    17.

    Impaired fasting glucose vs. glucose intolerance in pre-menopausal women: distinct metabolic entities and cardiovascular disease risk?

    Piché ME, Després JP, Pascot A, Nadeau A, Tremblay A, Weisnagel SJ, Bergeron J, Lemieux S.

    Diabet Med. 2004 Jul;21(7):730-7.PMID: 15209766 [PubMed - indexed for MEDLINE]Related articles

    18.

    Insulin secretion and insulin sensitivity pattern is different in isolated impaired glucose tolerance and impaired fasting glucose: the risk factor in Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.

    Hanefeld M, Koehler C, Fuecker K, Henkel E, Schaper F, Temelkova-Kurktschiev T; Impaired Glucose Tolerance for Atherosclerosis and Diabetes study.

    Diabetes Care. 2003 Mar;26(3):868-74.PMID: 12610051 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Metabolic characteristics of individuals with impaired fasting glucose and/or impaired glucose tolerance.

    Weyer C, Bogardus C, Pratley RE.

    Diabetes. 1999 Nov;48(11):2197-203.PMID: 10535454 [PubMed - indexed for MEDLINE]Related articlesFree article

    20.

    Changing the definition of impaired fasting glucose: impact on the classification of individuals and risk definition.

    Vaccaro O, Riccardi G.

    Diabetes Care. 2005 Jul;28(7):1786-8.PMID: 15983335 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity